2016 Hematological Malignancies

592 / 1835

Non random. ABC GCB Unclass.
Response rate (%): Molecular profile and arm
PR
CR/
CR(u)
90.2% 87.7% 88.0% 87.5% 90.5% 96.3% 81.8%